Skip to main content

$17.88 -0.10 (-0.56%)

High

$18.20

Low

$17.50

Trades

1,245

Turnover

$1,190,837

Volume

66,664
30 June 2023 at 4:10pm
Register to track CUV and receive email alerts.

Afamelanotide well tolerated by first stroke patients

StockBot

416,823 posts

CUV released this announcement to the ASX on 10 August 2021, 9:08. The announcement is not marked as price sensitive, and is 4 page(s) in length and 346.98kb in size.

You can view all announcements from CUV and see how they appear on a price chart on the announcements page.

At the date of this announcement, CUV was 4.385% short sold according to ASIC data. It was ranked the 24th most shorted stock on the ASX. It remains ranked 38th as of the latest reported data (05 May 2025).

Other Recent Announcements from CUV
Notification regarding unquoted securities - CUV 30 June 2023, 11:51
Two Grounds of Appeal Upheld by NICE Panel 30 June 2023, 9:17
Notification of cessation of securities - CUV 29 June 2023, 11:44
Afamelanotide well tolerated by first stroke patients 10 August 2021, 9:08
Quarterly Activities/Appendix 4C Cash Flow Report 29 July 2021, 9:21
Change of Director's Interest Notice 5 July 2021, 10:15
Change of Director's Interest Notice 29 June 2021, 9:26
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CUV and receive email alerts.